Ellipse Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Ellipse Technologies's estimated annual revenue is currently $2.8M per year.
- Ellipse Technologies's estimated revenue per employee is $251,000
Employee Data
- Ellipse Technologies has 11 Employees.
- Ellipse Technologies grew their employee count by -8% last year.
Ellipse Technologies's People
Name | Title | Email/Phone |
---|
Ellipse Technologies Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Ellipse Technologies?
Ellipse Technologies, Inc. is a privately held medical device company that is dedicated to the design, development, and successful commercialization of non-invasively adjustable, remote controlled implants for a broad spectrum of spinal and orthopedic applications.
keywords:N/AN/A
Total Funding
11
Number of Employees
$2.8M
Revenue (est)
-8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ellipse Technologies News
... who spoke at the rally Trump held on the White House Ellipse on Jan. ... technologies and offer advice for capitalizing on federal data.
... Orthopaedics (OrthoVirginia), Arthrex, Arthrosurface, DJO Global, Ellipse Technologies, Flower Orthopedics, Integra LifeSciences.
... technologies and offer advice for capitalizing on federal data. ... also said that Miller helped prepare Trump's remarks at the Ellipse.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1M | 11 | 0% | N/A |
#2 | $1M | 11 | 0% | N/A |
#3 | $1M | 11 | N/A | N/A |
#4 | $1.4M | 11 | -52% | N/A |
#5 | $1M | 11 | N/A | N/A |